BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹100 Cr | ₹94 Cr | ₹75 Cr | ₹67 Cr | ₹50 Cr |
What is the latest Sundry Debtors ratio of BAL PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹100 Cr |
Mar2023 | ₹94 Cr |
Mar2022 | ₹75 Cr |
Mar2021 | ₹67 Cr |
Mar2020 | ₹50 Cr |
How is Sundry Debtors of BAL PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹100 Cr | 6.01 | |
Mar2023 | ₹94 Cr | 24.78 | |
Mar2022 | ₹75 Cr | 12.08 | |
Mar2021 | ₹67 Cr | 35.47 | |
Mar2020 | ₹50 Cr | - |
Compare Sundry Debtors of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹147.1 Cr | -1.7% | -6.6% | -17.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -1.7% |
-6.6% |
-17.9% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses